Back to Awarded Treatment Trials
Awarded Trial: 07TGF-1112
Grant ID
07TGF-1112
Illness
Schizophrenia and Bipolar
Primary Drug/Intervention
Betahistine
Primary Dosage
8-24 mg b.i.d.
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Smith
Sample Size
40
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
AIMS, SAS, PAERS, BPRS, CGI-I, and CGI-S; concomitant medications; vital signs; BMI; height, weight, waist, and hip measures; whole body MRI; blood analyses for fasting levels of insulin, leptin, glucose, triglycerides, and cholesterol; eating behavior assessment; visual analog scale assessment of satiety
Results
N/A
Publication
N/A
Link
N/A
PI Name
Robert Smith
Degree
MD
Center
Department of Child and Adolescent Psychiatry
Institution
Columbia University/New York State Psychiatric Institute
Address
1051 Riverside Drive
City or Town
New York
State or Province
NY
Zip or Postal Code
10032
Country
USA
Email Address
Robert.Smith2@nyumc.org